Article summary
Reuters attributed a quote about access and reimbursement to Lynn Watkins at Monday's FDA hearing on psychedelic drugs. She didn't say it. What she did say, in two minutes on the federal record, was about chronic pain, facilitated touch during dosing, and moving all five toes for the first time in nine years.
Continue to the original publication for the complete article.